TMCnet News

BDC, KTH, DSCI, ONCY, SNTS Are Seasonally Ripe To Go Down In the Next Five Weeks
[March 14, 2013]

BDC, KTH, DSCI, ONCY, SNTS Are Seasonally Ripe To Go Down In the Next Five Weeks


Mar 14, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of BELDEN INC. (NYSE:BDC), Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi (NYSE:KTH), Derma Sciences Inc (NASDAQ:DSCI), ONCOLYTICS BIOTECH INC (NASDAQ:ONCY), Santarus Inc (NASDAQ:SNTS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date BDC BELDEN INC. -1.12% 100.00% (8 of 8) Friday, March 15th 2013 KTH Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi -2.90% 75.00% (9 of 12) Monday, April 22nd 2013 DSCI Derma Sciences Inc -5.45% 88.89% (8 of 9) Wednesday, March 20th 2013 ONCY ONCOLYTICS BIOTECH INC -1.41% 100.00% (11 of 11) Friday, March 15th 2013 SNTS Santarus Inc -3.85% 100.00% (8 of 8) Friday, March 15th 2013 BELDEN INC. (NYSE:BDC) - Belden Inc. engages in the design, manufacture, and marketing of cable, connectivity, and networking products for the industrial, enterprise, broadcast, and consumer electronics markets. Its products provide the transmission of signals for data, sound, and video applications. The company s cable products include copper cables, such as shielded and unshielded twisted pair cables, coaxial cables, and stranded cables; fiber optic cables, which transmit light signals through glass or plastic fibers; and composite cables that are combinations of multi conductor, coaxial, and fiber optic cables jacketed together or otherwise joined together to serve complex applications and provide ease of installation. Its connectivity products comprise fiber and copper connectors for the enterprise, broadcast, and industrial markets, as well as end-to-end structured cabling solutions; and networking products include industrial Ethernet switches and related equipment, fiber optic interfaces, and media converters used to bridge fieldbus networks over long distances, as well as load-moment indicators for mobile cranes and other load-bearing equipment. The company also designs, manufactures, and markets various industrial connectors for sensors and actuators, cord-sets, distribution boxes, and fieldbus communications, which are used as components of manufacturing equipment and in the installation and networking of such equipment. Belden Inc. sells its products through distributors, as well as directly to systems integrators, original equipment manufacturers, end-users, and installers. It primarily operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1902 and is headquartered in St. Louis, Missouri..



Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi (NYSE:KTH) - Structured Products Corp. 8.0% CorporateBacked Trust Securities Certifi.

Derma Sciences Inc (NASDAQ:DSCI) - Derma Sciences, Inc. operates as a medical technology company. The company provides advanced wound care products, including Medihoney dressings that are used for the management of non-chronic and hard-to-heal wounds, such as chronic ulcers, burns, and post-operative wounds; Bioguard dressings that are used for prophylactic use in the prevention of hospital or community acquired infections through wound sites; Algicell Ag, antimicrobial dressings; Xtrasorb dressings that convert fluid within the dressings to a gel and lock the exudates into the dressings; TCC-EZ, a dressing system for the management of diabetic foot ulcers; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and Dermagran products. It also offers traditional wound care products, such as of gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices, as well as adhesive bandages and related first aid products. In addition, the company provides pharmaceutical wound care products, including DSC127, an angiotensin analog for use in wound healing and scar reduction. It markets wound closure strips, nasal tube and catheter fasteners, barrier creams and ointments, antibacterial cleansing foams and sprays, shampoos and body washes, hand sanitizers, bath additives, body oils, and moisturizers to doctors, clinics, nursing homes, hospitals, home healthcare agencies, and other institutions. The company sells its products to health care providers, such as wound care centers, extended care facilities, acute care facilities, home health care agencies, and physicians offices through direct sales representatives in the United States, Canada, and the United Kingdom; retail channels; manufacturers representatives and independent distributors in international markets. Derma Sciences, Inc. was founded in 1984 and is headquartered in Princeton, New Jersey..


ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) - Oncolytics Biotech Inc., a biotechnology company, focuses on the development of oncolytic viruses as potential cancers therapeutics. The company develops REOLYSIN, a human cancer therapeutic. Its clinical program includes various human trials comprising a Phase III clinical trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus. Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada..

Santarus Inc (NASDAQ:SNTS) - Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company sells metformin hydrochloride extended release tablets under the Glumetza name and bromocriptine mesylate tablets under the CYCLOSET name, which are indicated to treat type 2 diabetes; fenofibrate tablets under Fenoglide name that is used to treat primary hyperlipidemia or mixed dyslipidemia; and omeprazole/sodium bicarbonate capsules and powder for oral suspension under Zegerid name for the treatment of upper GI conditions, including gastroesophageal reflux disease. Its products under development include budesonide MMX, which is in Phase IIIb clinical studies for the induction of remission of mild to moderate active ulcerative colitis; Rhucin (recombinant human C1 inhibitor) under Phase III clinical studies for the treatment of acute attacks of hereditary angioedema; Rifamycin SV MMX, a semi-synthetic antibiotic, which is in Phase III clinical studies for the treatment of travelers diarrhea; and SAN-300 under Phase I clinical study for the treatment of rheumatoid arthritis. Santarus, Inc. has strategic alliance agreements with Merck & Co., Inc.; GlaxoSmithKline, plc.; and Cosmo Technologies Limited. The company was founded in 1996 and is headquartered in San Diego, California..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 [email protected] SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to [email protected].

[ Back To TMCnet.com's Homepage ]